Literature DB >> 16197513

NMDA and dopamine interactions in the nucleus accumbens modulate cortical acetylcholine release.

Amy Zmarowski1, Martin Sarter, John P Bruno.   

Abstract

The nucleus accumbens (NAC) plays a key role in directing appropriate motor output following the presentation of behaviorally relevant stimuli. As such, we postulate that accumbens efferents also participate in the modulation of neuronal circuits regulating attentional processes directed toward the identification and selection of these stimuli. In this study, N-methyl-d-aspartate (NMDA) and D1 ligands were perfused into the shell region of the NAC of awake rats. Cortical cholinergic transmission, a mediator of attentional processes, was measured via microdialysis probes inserted into the prefrontal cortex (PFC). NMDA perfusions (150 or 250 microm) into NAC resulted in significant increases in acetylcholine (ACh) efflux in PFC (150-200% above baseline levels). Co-administration of the D1 antagonist SCH-23390 (150 microm) markedly attenuated (by approx. 70%) ACh efflux following perfusions of 150 microm NMDA but not following 250 microm NMDA, suggesting that D1 receptor activity contributes to the ability of the lower but not the higher concentration of NMDA to increase cortical ACh release. Collectively, these data reveal a positive modulation of NMDA receptors by D1 receptors in NAC that is expressed trans-synaptically at the level of cortical transmission. This modulation may underlie the coordinated linking of attentional processes and motor output following exposure to salient and behaviorally relevant stimuli.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16197513     DOI: 10.1111/j.1460-9568.2005.04333.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  21 in total

Review 1.  Phasic acetylcholine release and the volume transmission hypothesis: time to move on.

Authors:  Martin Sarter; Vinay Parikh; W Matthew Howe
Journal:  Nat Rev Neurosci       Date:  2009-05       Impact factor: 34.870

2.  Transient inactivation of the neonatal ventral hippocampus permanently disrupts the mesolimbic regulation of prefrontal cholinergic transmission: implications for schizophrenia.

Authors:  Julie M Brooks; Martin Sarter; John P Bruno
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

3.  Prefrontal beta2 subunit-containing and alpha7 nicotinic acetylcholine receptors differentially control glutamatergic and cholinergic signaling.

Authors:  Vinay Parikh; Jinzhao Ji; Michael W Decker; Martin Sarter
Journal:  J Neurosci       Date:  2010-03-03       Impact factor: 6.167

4.  Modeling deficits in attention, inhibition, and flexibility in HAND.

Authors:  Landhing M Moran; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neuroimmune Pharmacol       Date:  2014-04-25       Impact factor: 4.147

Review 5.  Deficits in attentional control: cholinergic mechanisms and circuitry-based treatment approaches.

Authors:  Martin Sarter; Giovanna Paolone
Journal:  Behav Neurosci       Date:  2011-12       Impact factor: 1.912

Review 6.  Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction.

Authors:  Heath D Schmidt; R Christopher Pierce
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

7.  Enhanced control of attention by stimulating mesolimbic-corticopetal cholinergic circuitry.

Authors:  Megan St Peters; Elise Demeter; Cindy Lustig; John P Bruno; Martin Sarter
Journal:  J Neurosci       Date:  2011-06-29       Impact factor: 6.167

Review 8.  nAChR agonist-induced cognition enhancement: integration of cognitive and neuronal mechanisms.

Authors:  Martin Sarter; Vinay Parikh; William M Howe
Journal:  Biochem Pharmacol       Date:  2009-05-04       Impact factor: 5.858

9.  Prefrontal acetylcholine release controls cue detection on multiple timescales.

Authors:  Vinay Parikh; Rouba Kozak; Vicente Martinez; Martin Sarter
Journal:  Neuron       Date:  2007-10-04       Impact factor: 17.173

10.  Disruption of mesolimbic regulation of prefrontal cholinergic transmission in an animal model of schizophrenia and normalization by chronic clozapine treatment.

Authors:  Kathleen S Alexander; Julie M Brooks; Martin Sarter; John P Bruno
Journal:  Neuropsychopharmacology       Date:  2009-08-19       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.